Clinical Results of Perftoran Application: Present and Future

@article{Maevsky2005ClinicalRO,
  title={Clinical Results of Perftoran Application: Present and Future},
  author={Eugene I. Maevsky and Genrih Ivanitsky and Ludmila Bogdanova and Olga V Axenova and Natalia Karmen and Eugene Zhiburt and R. Yu. Senina and S. Yu. Pushkin and Igor Alexeevitch Maslennikov and Andrey Orlov and I. G. Marinicheva},
  journal={Artificial Cells, Blood Substitutes, and Biotechnology},
  year={2005},
  volume={33},
  pages={37 - 46}
}
Clinical experience of Perftoran (commercial drug of low concentrated perfluorocheminal emulsion) applications is presented in some statistical data and in brief analysis of clinical trials and following clinical studies described in the Russian scientific literature. Observed data allow us to suppose that Perftoran facilitates oxygen delivery together with remaining red blood cells at blood replacements and will have more wider area for application than just a blood substitute. Its infusion… Expand
Perftoran (Vidaphor)—Introduction to Western Medicine
Perftoran, which has been rebranded as Vidaphor for marketing in North America, is an emulsion of perfluorocarbons in a surfactant and electrolyte mixture. It was developed in Russia as anExpand
Military Supplement: Perfluorocarbon Emulsions, Platelet Counts and Inflammation.
TLDR
Although thrombocytopenia has been reported in response to PFC emulsion formulations it is not ubiquitous and seems to be less associated with some formulations, and in some recent animal studies there is no evidence of platelet white cell adverse interactions. Expand
Oxygen therapeutics: perfluorocarbons and blood substitute safety.
TLDR
The authors discuss the attributes of an ideal blood substitute, and the mechanism and current status of perfluorocarbons; they also review the shortcomings of all oxygen therapeutic products in development today. Expand
Military Supplement: Perfluorocarbon Gas Transport: An Overview of Medical History with Yet Unrealized Potentials.
TLDR
The PFCs should be viewed as pharmaceuticals possessing unique gas solubility and diffusion characteristics such that they may relieve ischemia of tissues with low/flow-no flow states therefore they can enhance tissue salvage while other definitive treatments are being sought. Expand
Importância dos carreadores de oxigênio livre de células
TLDR
The understanding of free oxygen carrying cell mechanisms has made testing of a new generation of these products for other applications possible thereby expanding transfusion medicine frontiers. Expand
Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice
TLDR
The encapsulation of PFC with amphiphilic biopolymers, such as albumin, offers a new option to achieve the required biocompatibility avoiding toxic emulsifiers, and recent studies with PFC nanocapsules show promising results. Expand
Klinično vodenje transfuzije - sodobni pristopi za optimizacijo transfuzije Patient Blood Management-modern approaches to optimization of blood transfusion
TLDR
The article deals with the current modern approaches to optimization of transfusion practice and patient blood management that have to be implemented in Slovenian hospitals. Expand
Blood substitutes: from chemistry to clinic
Blood substitutes are oxygen-carrying fluids that aim to provide an alternative to the transfusion of blood. Strategies for developing such substitutes have involved the production of materials basedExpand
Search for the ideal blood substitute – current status
Synthetic blood substitutes are substances produced to fulfill functions of biological blood and serve as it’s replacers in diverse medical procedures. Their main function is to restore blood volumeExpand
Bio-inspired nanomedicine strategies for artificial blood components.
  • A. Sen Gupta
  • Medicine
  • Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
  • 2017
TLDR
This study provides a comprehensive review of the various nanotechnology approaches to design synthetic blood cells, along with a critical discussion of successes and challenges of the current state-of-art in this field. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
[The use of a perfluorocarbon emulsion in the local treatment of wounds complicated by a surgical infection].
TLDR
Perftoran maintains the intensified development of young cell elements at different periods of healing of the purulent wounds, decreases the propagation of microorganisms in them, lessens the wound square surface, and results in earlier development of marginal epithelialization and formation of the elastic cicatrix. Expand
The use of a perfluorocarbon emulsion in the local treatment of wounds complicated by a surgical infection
TLDR
Perftoran maintains the intensified development of young cell elements at different periods of healing of the purulent wounds, decreases the propagation of microorganisms in them, lessens the wound square surface, and results in earlier development of marginal epithelialization and formation of the elastic cicatrix. Expand
Perftoran infusion in acute myocardial infarction
TLDR
After the infusion of perfluorane, the number of functioning capillaries increased, venous congestion decreased, arteriolar and venular diameters increased, and hypercoagulation was corrected. Expand
[Perftoran infusion in acute myocardial infarction].
TLDR
After the infusion of perfluorane, the number of functioning capillaries increased, venous congestion decreased, arteriolar and venular diameters increased, and hypercoagulation was corrected. Expand
Uncoupling of the liver monooxygenase system by perfluorocarbons in vivo
: Administration of a perfluorodecalin (PFD) emulsion, the liver cytochrome P-450 II B1/B2 inducer, to experimental animals is followed by a two-fold increase of the NADPH oxidation rate in liverExpand
[Uncoupling of the liver monooxygenase system by perfluorocarbons in vivo].
TLDR
It is suggested that the accelerated weight loss in starved animals following PFD administration is due to the energy dissipation in the fluorocarbon uncoupled monooxygenase reactions in the liver. Expand
Activity of serum elastase at the perftoran treatment of patients with traumatic injuries of spinal cord
  • Perfluoroorganic Compounds in Medicine and Biology
  • 2002
Activity of serum elastase at the perftoran treatment of patients with traumatic injuries of spinal cord. (Russian) In: Perfluoroorganic Compounds in Medicine and Biology
  • Pushkin, R.Ya. Senina. (Russian)
  • 2002
Treatment of neurotrophic ulcers in leprosy patients with the use emulsion perftoran
  • Perfluoroorganic Compounds in Medicine and Biology. Eds. G.R. Ivanitscy,
  • 2002
Treatment of neurotrophic ulcers in leprosy patients with the use emulsion perftoran. (Russian) In: Perfluoroorganic Compounds in Medicine and Biology
  • 2002
...
1
2
3
4
...